secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2025-12-30T23:59:59+00:00
Accession:  0001493152-25-029513
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics files 1-for-30 reverse stock split to regain Nasdaq minimum bid price compliance
--------------------------------------------------------------------------------

- Reverse stock split ratio set at 1-for-30; effective January 2, 2026 at 12:01 a.m. ET.
- Approximately 2,095,031 shares outstanding post-split; new CUSIP 189763204; ticker CODX unchanged.
- Fractional shares rounded up to next whole share; no fractional shares issued.
- Split intended to enable compliance with Nasdaq $1.00 minimum bid price listing requirement.
- Board approved ratio on Dec 29, 2025; stockholders authorized up to 1-for-30 at Dec 5 special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225029513/0001493152-25-029513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225029513/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-029513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer